Metraipolis › archive › dc_3ffe551e2adb
CRB-701: A Second-generation Nectin-4-Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors — Europe PMC PMID:42636059
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42636059
- DOI
- 10.1158/2767-9764.crc-25-0799
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T12:59:23.898Z
- SHA-256 of the archived text
037cd44ea3a2b7bdc0e43501f150833e08ee00d2ba8f5e576e797c1d9ec02c00- Stable URL of this page
https://metraipolis.com/documento/dc_3ffe551e2adb
How to cite
CRB-701: A Second-generation Nectin-4-Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors — Europe PMC PMID:42636059 — Europe PMC (en), https://europepmc.org/article/MED/42636059 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ffe551e2adb (Metraipolis archive dc_3ffe551e2adb, sha256 037cd44ea3a2b7bdc0e43501f150833e08ee00d2ba8f5e576e797c1d9ec02c00)
BibTeX
@misc{dc3ffe551e2adb,
title = {CRB-701: A Second-generation Nectin-4-Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors — Europe PMC PMID:42636059},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42636059},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ffe551e2adb; sha256 037cd44ea3a2b7bdc0e43501f150833e08ee00d2ba8f5e576e797c1d9ec02c00},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42636059. Agents can read the archived copy with the MCP tool read_document.